Boxed Warning on risk of severe hypocalcaemia with denosumab

被引：0
作者：
机构：
来源：
Reactions Weekly | 2024年 / 1992卷 / 1期
关键词：
D O I：
10.1007/s40278-024-52736-3
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3 / 3
相关论文
共 50 条
  • [1] Denosumab information updated with risk of severe hypocalcaemia
    Reactions Weekly, 2024, 1994 (1) : 1 - 1
  • [2] Denosumab/PrednisoloneOsteoporosis and severe hypocalcaemia
    Reactions Weekly, 2024, 2002 (1) : 161 - 161
  • [3] Severe hypocalcaemia post-denosumab
    Martin-Baez, Isabel M.
    Blanco-Garcia, Raquel
    Alonso-Suarez, Mario
    Cossio-Aranibar, Cynthia
    Beato-Coo, Laura V.
    Fernandez-Fleming, Francisco
    NEFROLOGIA, 2013, 33 (04): : 614 - 615
  • [4] Severe hypocalcaemia following denosumab and iron infusion
    Cohen, Adrienne
    Chacko, Bobby
    NEPHROLOGY, 2022, 27 (09) : 781 - 782
  • [5] Denosumab and risk of hypocalcaemia ... and other research
    Nolan, Tom
    BMJ-BRITISH MEDICAL JOURNAL, 2024, 387
  • [6] Hypocalcaemia risk with concomitant denosumab and cinacalcet
    Reactions Weekly, 2021, 1886 (1) : 2 - 2
  • [7] Safety information regarding the risk of severe and sometimes fatal hypocalcaemia with denosumab [XGEVA]
    Reactions Weekly, 2012, 1416 (1) : 5 - 5
  • [8] SEVERE HYPOCALCAEMIA AND HYPOPHOSPHATAEMIA FOLLOWING INTRAVENOUS IRON AND DENOSUMAB
    Smyth, B.
    Ong, S.
    NEPHROLOGY, 2015, 20 : 61 - 61
  • [9] Severe symptomatic hypocalcaemia following a single dose of denosumab
    McLachlan, Jennifer M.
    Marx, Gavin M.
    Bridgman, Margaret
    MEDICAL JOURNAL OF AUSTRALIA, 2013, 199 (04) : 242 - 243
  • [10] Evaluation of the risk of Denosumab-Associated Hypocalcaemia
    Krahenbule, A.
    Morel, A.
    Aubert, L.
    Azzouz, B.
    Trenque, T.
    DRUG SAFETY, 2017, 40 (10) : 1025 - 1025
12345